In the latest trading session, 1.05 million Nevro Corp (NYSE:NVRO) shares changed hands as the company’s beta touched 0.88. With the company’s most recent per share price at $5.49 changing hands around $0.17 or 3.23% at last look, the market valuation stands at $204.76M. NVRO’s current price is a discount, trading about -312.39% off its 52-week high of $22.64. The share price had its 52-week low at $4.38, which suggests the last value was 20.22% up since then. When we look at Nevro Corp’s average trading volume, we note the 10-day average is 0.64 million shares, with the 3-month average coming to 519.96K.

Analysts gave the Nevro Corp (NVRO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.44. If we narrow down to specifics, the data shows that 2 out of 15 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 6 recommended NVRO as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Nevro Corp’s EPS for the current quarter is expected to be -0.67.

Nevro Corp (NYSE:NVRO) trade information

Instantly NVRO is in green as seen in intraday trades today. With action -1.22%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -74.48%, with the 5-day performance at -1.22% in the red. However, in the 30-day time frame, Nevro Corp (NYSE:NVRO) is 11.62% up. Looking at the short shares, we see there were 3.13 million shares sold at short interest cover period of 7.25 days.

The consensus price target for the stock as assigned by Wall Street analysts is 7, meaning bulls need an upside of 21.57% from its recent market value. According to analyst projections, NVRO’s forecast low is 5 with 125 as the target high. To hit the forecast high, the stock’s price needs a -2176.87% plunge from its current level, while the stock would need to tank 8.93% for it to hit the projected low.

Nevro Corp (NVRO) estimates and forecasts

Data shows that the Nevro Corp share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -44.41% over the past 6 months, a -9.35% in annual growth rate that is considerably lower than the industry average of 15.90%. Year-over-year growth is forecast to reach -5.30% down from the last financial year.

Consensus estimates given by 15 financial analysts project the company’s revenue in the current quarter to hit an average of 103.33M. 11 analysts are of the opinion that Nevro Corp’s revenue for the current quarter will be 100.34M. The company’s revenue for the corresponding quarters a year ago was 116.18M and 97.89M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -11.10%. The estimates for the next quarter sales put growth at 2.50%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -9.37%. The 2024 estimates are for Nevro Corp earnings to increase by 4.39%.

NVRO Dividends

Nevro Corp is expected to release its next quarterly earnings report on 2025-Feb-19.

Nevro Corp (NYSE:NVRO)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 3.73% of Nevro Corp shares while 96.48% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 100.22%. There are 96.48% institutions holding the Nevro Corp stock share, with ARROWMARK COLORADO HOLDINGS LLC the top institutional holder. As of 2024-06-30, the company held 11.7615% of the shares, roughly 4.29 million NVRO shares worth $36.11 million.

ARMISTICE CAPITAL, LLC holds the second largest percentage of outstanding shares, with 10.0693% or 3.67 million shares worth $30.92 million as of 2024-06-30.